Loading...
XSTO
BIOT
Market cap1.19bUSD
Jun 13, Last price  
142.60SEK
1D
0.07%
1Q
33.40%
Jan 2017
210.68%
IPO
42.60%
Name

Biotage AB

Chart & Performance

D1W1MN
XSTO:BIOT chart
No data to show
P/E
39.74
P/S
5.49
EPS
3.59
Div Yield, %
1.12%
Shrs. gr., 5y
4.21%
Rev. gr., 5y
13.30%
Revenues
2.06b
+10.42%
430,396,000519,497,000496,402,000385,295,000394,123,000428,926,000428,408,000462,941,000444,645,000490,381,000610,534,000667,912,000748,147,000910,896,0001,101,373,0001,092,278,0001,232,000,0001,566,000,0001,862,000,0002,056,000,000
Net income
284m
+15.45%
-39,892,0002,816,00099,373,000299,054,00013,478,000-410,243,00032,475,00038,336,00041,392,00051,112,00073,255,00092,796,000138,747,000167,627,000186,820,000175,000,000205,000,000268,000,000246,000,000284,000,000
CFO
413m
+45.42%
-20,291,00039,908,00033,718,00088,737,00036,248,00057,595,000109,049,00074,472,00056,757,00080,906,000120,078,000139,072,000168,932,000155,005,000211,807,000279,047,000353,000,000341,000,000284,000,000413,000,000
Dividend
Apr 26, 20241.6 SEK/sh
Earnings
Jul 14, 2025

Profile

Biotage AB (publ) provides separation technologies in the areas of organic and analytical chemistry, biomolecules, and industrial scale up applications. The company offers organic and peptide synthesis solutions; flash chromotherapy, evaporation, and work-up products; flash systems and flash system accessories; normal, reversed, and speciality phase cartridges; plasmid purification solutions; and metal scavengers and reagents, as well as accessories and spare parts. It also provides sample preparation solutions in the clinical and bioanalytical, forensic and toxicology, doping control animal and human, environment, and food and agriculture areas, as well as consumables and systems; protein purification solutions, including antibody and tagged proteins purification, automation systems, and custom packing service, as well as ion exchange, reversed phase, normal phase, and gel filtration PhyTip columns. The company sells its products to pharmaceutical and biotechnical companies, contract research and manufacturing organizations, and government authorities and academic institutions, as well as clinical, forensic, and academic laboratories. It operates in 70 countries, which include Americas, Europe, the Middle East, Africa, and Asia Pacific. Biotage AB (publ) was founded in 1969 and is headquartered in Uppsala, Sweden.
URL
https://www.biotage.com/
IPO date
Jun 30, 2000
Employees
527
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
2,056,000
10.42%
1,862,000
18.90%
1,566,000
27.11%
Cost of revenue
1,744,000
1,580,000
1,256,000
Unusual Expense (Income)
NOPBT
312,000
282,000
310,000
NOPBT Margin
15.18%
15.15%
19.80%
Operating Taxes
44,000
57,000
80,000
Tax Rate
14.10%
20.21%
25.81%
NOPAT
268,000
225,000
230,000
Net income
284,000
15.45%
246,000
-8.21%
268,000
30.73%
Dividends
(128,000)
(106,000)
(102,000)
Dividend yield
0.99%
1.07%
0.83%
Proceeds from repurchase of equity
2,000
2,000
BB yield
-0.02%
-0.02%
Debt
Debt current
34,000
33,000
25,000
Long-term debt
316,000
335,000
259,000
Deferred revenue
Other long-term liabilities
3,000
150,000
22,000
Net debt
(84,000)
(241,000)
(172,000)
Cash flow
Cash from operating activities
413,000
284,000
341,000
CAPEX
(89,000)
(26,000)
(70,000)
Cash from investing activities
(456,000)
35,000
(84,000)
Cash from financing activities
(156,000)
(142,000)
(133,000)
FCF
73,000
74,000
170,000
Balance
Cash
434,000
594,000
441,000
Long term investments
15,000
15,000
Excess cash
331,200
515,900
377,700
Stockholders' equity
1,650,000
1,366,000
1,356,000
Invested Capital
4,034,800
3,550,100
1,498,300
ROIC
7.07%
8.91%
16.06%
ROCE
6.85%
6.62%
15.92%
EV
Common stock shares outstanding
80,100
73,994
66,184
Price
160.80
20.27%
133.70
-27.92%
185.50
-29.20%
Market cap
12,880,016
30.19%
9,893,056
-19.42%
12,277,192
-28.42%
EV
12,796,016
9,652,056
12,105,192
EBITDA
497,000
404,000
412,000
EV/EBITDA
25.75
23.89
29.38
Interest
11,000
5,000
Interest/NOPBT
3.90%
1.61%